copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Daniel O’Day - Gilead Sciences Daniel O’Day Chairman and Chief Executive Officer, Gilead Sciences Mr O’Day joined Gilead in March 2019 as Chairman of the Board of Directors and Chief Executive Officer Prior to Gilead, Mr O’Day served as the Chief Executive Officer of Roche Pharmaceuticals
Daniel O’Day of Gilead Sciences Becomes New Chair of PhRMA Board | PhRMA WASHINGTON, D C (February 21, 2024) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Gilead Sciences Chairman and CEO Daniel O’Day has assumed the role of chair of the PhRMA Board of Directors Albert Bourla of Pfizer and Paul Hudson of Sanofi also assumed new leadership positions on the PhRMA board
Derek Spencer - Executive Director, Gilead Sciences - LinkedIn Gilead Sciences is dedicated to developing innovative medicines for life-threatening illnesses Through bold and transformative science, we look to create a healthier world for all people
Daniel ODay, CEO of Gilead Sciences - ceobase. io Daniel O'Day is the CEO of Gilead Sciences, a top player in the pharmaceutical industry known for its focus on treatments for serious diseases like HIV and hepatitis He took the reins at Gilead on March 1, 2019, after a
Leadership | Gilead - Gilead Sciences Meet the Gilead Senior Management team and the board of directors and learn more about their roles within Gilead Sciences, Inc
10 Things You Didnt Know about Daniel ODay - Money Inc 10 Things You Didn’t Know about Daniel O’Day By Allen Lee Posted on May 17, 2020 Updated on November 26, 2021 Daniel O’Day is both the CEO and the Chairman of the Board for Gilead Sciences For those who are unfamiliar, Gilead Sciences is a U S -based corporation that creates and commercializes pharmaceutical products